AIM ImmunoTech is trading 5.7% up today at $0.28 amid broader sector momentum and a lack of company-specific news.

  • The stock is extending a volatile multi-day rebound after previously trading at sub-$0.25 levels.
  • No fresh SEC filings, clinical updates, or FDA headlines have been released to explain the recent price action.
  • The move coincides with gains in biotech benchmarks like the XBI during a risk-on trading session.